| Dr Gregory S Harrison, MD | |
|
777 Hospital Way, Suite 115, Pocatello, ID 83201-5175 | |
| (208) 239-2260 | |
| (208) 239-3767 |
| Full Name | Dr Gregory S Harrison |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 29 Years |
| Location | 777 Hospital Way, Pocatello, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104825892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 44711 (Minnesota) | Secondary |
| 207T00000X | Neurological Surgery | M11193 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Mccall | Mccall, ID | Hospital |
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Researchers at Inserm and Paris Descartes University have just taken an important step in research on stem cells and dental repair. They have managed to isolate dental stem cell lines and to describe the natural mechanism by which they repair lesions in the teeth. This fundamental discovery will make it possible to initiate unprecedented therapeutic strategies to mobilise the resident dental stem cells and magnify their natural capacity for repair.
Epitomics, Inc. today announced that it has spun-out to its shareholders a new biotechnology company called Apexigen, Inc., which will focus on the development and commercialization of humanized monoclonal antibodies for treatment of cancer and immuno-disorders.
Operators beyond the confines of conventional emergency healthcare are willing and able to assist in a crisis, a University of Gothenburg study shows.
› Verified 8 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Researchers at Inserm and Paris Descartes University have just taken an important step in research on stem cells and dental repair. They have managed to isolate dental stem cell lines and to describe the natural mechanism by which they repair lesions in the teeth. This fundamental discovery will make it possible to initiate unprecedented therapeutic strategies to mobilise the resident dental stem cells and magnify their natural capacity for repair.
Epitomics, Inc. today announced that it has spun-out to its shareholders a new biotechnology company called Apexigen, Inc., which will focus on the development and commercialization of humanized monoclonal antibodies for treatment of cancer and immuno-disorders.
Operators beyond the confines of conventional emergency healthcare are willing and able to assist in a crisis, a University of Gothenburg study shows.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory S Harrison, MD Po Box 4168, Pocatello, ID 83205-4168 Ph: (208) 239-2055 | Dr Gregory S Harrison, MD 777 Hospital Way, Suite 115, Pocatello, ID 83201-5175 Ph: (208) 239-2260 |
News Archive
In an episode of Al Jazeera's "Inside Story," presenter Shiulie Ghosh and guests Chandra Bhushan, a climate change scientist and deputy director of the Centre for Science and Environment; Deborah Doane, the director of the World Development Movement and a specialist on corporate power who also blogs on food politics; and Philip Thornton of the Consultative Group on International Agricultural Research (CGIAR) examine the politics of global food security.
Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.
Researchers at Inserm and Paris Descartes University have just taken an important step in research on stem cells and dental repair. They have managed to isolate dental stem cell lines and to describe the natural mechanism by which they repair lesions in the teeth. This fundamental discovery will make it possible to initiate unprecedented therapeutic strategies to mobilise the resident dental stem cells and magnify their natural capacity for repair.
Epitomics, Inc. today announced that it has spun-out to its shareholders a new biotechnology company called Apexigen, Inc., which will focus on the development and commercialization of humanized monoclonal antibodies for treatment of cancer and immuno-disorders.
Operators beyond the confines of conventional emergency healthcare are willing and able to assist in a crisis, a University of Gothenburg study shows.
› Verified 8 days ago
William Scott Huneycutt, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2240 E Center St, Pocatello, ID 83201 Phone: 208-233-8344 Fax: 208-233-6983 | |
Jonathan T Morgan, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave, Suite B4, Pocatello, ID 83201 Phone: 208-232-2233 Fax: 208-232-2299 |